Glucagon-like peptide-1 analog
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Glucagon-like peptide-1 analogs are a new class of drug for treatment of type 2 diabetes. [1] One of their advantages is that they have a lower risk of causing hypoglycemia.
Licenced:
- exenatide (2005)
Under investigation:
- albiglutide
- taspoglutide
References
- ↑ http://www.medscape.com/viewarticle/578304 “Glucagon-like Peptide-1 Analogs Other Than Exenatide”
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH